Cargando…

DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways

While it is considered one of the most common cancers and the leading cause of death in men worldwide, prognostic stratification and treatment modalities are still limited for patients with prostate cancer (PCa). Recently, the introduction of genomic profiling and the use of new techniques like next...

Descripción completa

Detalles Bibliográficos
Autores principales: Shareef, Zainab Al, Hachim, Mahmood Y., Talaat, Iman M., Bhamidimarri, Poorna Manasa, Ershaid, Mai Nidal Asad, Ilce, Burcu Yener, Venkatachalam, Thenmozhi, Eltayeb, Abdulla, Hamoudi, Rifat, Hachim, Ibrahim Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947504/
https://www.ncbi.nlm.nih.gov/pubmed/36845147
http://dx.doi.org/10.3389/fimmu.2023.978236
_version_ 1784892569926238208
author Shareef, Zainab Al
Hachim, Mahmood Y.
Talaat, Iman M.
Bhamidimarri, Poorna Manasa
Ershaid, Mai Nidal Asad
Ilce, Burcu Yener
Venkatachalam, Thenmozhi
Eltayeb, Abdulla
Hamoudi, Rifat
Hachim, Ibrahim Y.
author_facet Shareef, Zainab Al
Hachim, Mahmood Y.
Talaat, Iman M.
Bhamidimarri, Poorna Manasa
Ershaid, Mai Nidal Asad
Ilce, Burcu Yener
Venkatachalam, Thenmozhi
Eltayeb, Abdulla
Hamoudi, Rifat
Hachim, Ibrahim Y.
author_sort Shareef, Zainab Al
collection PubMed
description While it is considered one of the most common cancers and the leading cause of death in men worldwide, prognostic stratification and treatment modalities are still limited for patients with prostate cancer (PCa). Recently, the introduction of genomic profiling and the use of new techniques like next-generation sequencing (NGS) in many cancers provide novel tools for the discovery of new molecular targets that might improve our understanding of the genomic aberrations in PCa and the discovery of novel prognostic and therapeutic targets. In this study, we investigated the possible mechanisms through which Dickkopf-3 (DKK3) produces its possible protective role in PCa using NGS in both the DKK3 overexpression PCa cell line (PC3) model and our patient cohort consisting of nine PCa and five benign prostatic hyperplasia. Interestingly, our results have shown that DKK3 transfection-modulated genes are involved in the regulation of cell motility, senescence-associated secretory phenotype (SASP), and cytokine signaling in the immune system, as well as in the regulation of adaptive immune response. Further analysis of our NGS using our in vitro model revealed the presence of 36 differentially expressed genes (DEGs) between DKK3 transfected cells and PC3 empty vector. In addition, both CP and ACE2 genes were differentially expressed not only between the transfected and empty groups but also between the transfected and Mock cells. The top common DEGs between the DKK3 overexpression cell line and our patient cohort are the following: IL32, IRAK1, RIOK1, HIST1H2BB, SNORA31, AKR1B1, ACE2, and CP. The upregulated genes including IL32, HIST1H2BB, and SNORA31 showed tumor suppressor functions in various cancers including PCa. On the other hand, both IRAK1 and RIOK1 were downregulated and involved in tumor initiation, tumor progression, poor outcome, and radiotherapy resistance. Together, our results highlighted the possible role of the DKK3-related genes in protecting against PCa initiation and progression.
format Online
Article
Text
id pubmed-9947504
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99475042023-02-24 DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways Shareef, Zainab Al Hachim, Mahmood Y. Talaat, Iman M. Bhamidimarri, Poorna Manasa Ershaid, Mai Nidal Asad Ilce, Burcu Yener Venkatachalam, Thenmozhi Eltayeb, Abdulla Hamoudi, Rifat Hachim, Ibrahim Y. Front Immunol Immunology While it is considered one of the most common cancers and the leading cause of death in men worldwide, prognostic stratification and treatment modalities are still limited for patients with prostate cancer (PCa). Recently, the introduction of genomic profiling and the use of new techniques like next-generation sequencing (NGS) in many cancers provide novel tools for the discovery of new molecular targets that might improve our understanding of the genomic aberrations in PCa and the discovery of novel prognostic and therapeutic targets. In this study, we investigated the possible mechanisms through which Dickkopf-3 (DKK3) produces its possible protective role in PCa using NGS in both the DKK3 overexpression PCa cell line (PC3) model and our patient cohort consisting of nine PCa and five benign prostatic hyperplasia. Interestingly, our results have shown that DKK3 transfection-modulated genes are involved in the regulation of cell motility, senescence-associated secretory phenotype (SASP), and cytokine signaling in the immune system, as well as in the regulation of adaptive immune response. Further analysis of our NGS using our in vitro model revealed the presence of 36 differentially expressed genes (DEGs) between DKK3 transfected cells and PC3 empty vector. In addition, both CP and ACE2 genes were differentially expressed not only between the transfected and empty groups but also between the transfected and Mock cells. The top common DEGs between the DKK3 overexpression cell line and our patient cohort are the following: IL32, IRAK1, RIOK1, HIST1H2BB, SNORA31, AKR1B1, ACE2, and CP. The upregulated genes including IL32, HIST1H2BB, and SNORA31 showed tumor suppressor functions in various cancers including PCa. On the other hand, both IRAK1 and RIOK1 were downregulated and involved in tumor initiation, tumor progression, poor outcome, and radiotherapy resistance. Together, our results highlighted the possible role of the DKK3-related genes in protecting against PCa initiation and progression. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9947504/ /pubmed/36845147 http://dx.doi.org/10.3389/fimmu.2023.978236 Text en Copyright © 2023 Shareef, Hachim, Talaat, Bhamidimarri, Ershaid, Ilce, Venkatachalam, Eltayeb, Hamoudi and Hachim https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Shareef, Zainab Al
Hachim, Mahmood Y.
Talaat, Iman M.
Bhamidimarri, Poorna Manasa
Ershaid, Mai Nidal Asad
Ilce, Burcu Yener
Venkatachalam, Thenmozhi
Eltayeb, Abdulla
Hamoudi, Rifat
Hachim, Ibrahim Y.
DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title_full DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title_fullStr DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title_full_unstemmed DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title_short DKK3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
title_sort dkk3’s protective role in prostate cancer is partly due to the modulation of immune-related pathways
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947504/
https://www.ncbi.nlm.nih.gov/pubmed/36845147
http://dx.doi.org/10.3389/fimmu.2023.978236
work_keys_str_mv AT shareefzainabal dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT hachimmahmoody dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT talaatimanm dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT bhamidimarripoornamanasa dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT ershaidmainidalasad dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT ilceburcuyener dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT venkatachalamthenmozhi dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT eltayebabdulla dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT hamoudirifat dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways
AT hachimibrahimy dkk3sprotectiveroleinprostatecancerispartlyduetothemodulationofimmunerelatedpathways